| BNY MELLON GLOBAL EMERGING MARKETS OPPORTUNITIES FUND INSTITUTIONAL W (ACC) GBP | RVI EMERGENTES | 14,87% | 24,35% | 5,01% | 151,63% |
| CARMIGNAC PORTFOLIO EMERGENTS FW GBP ACC | RVI EMERGENTES | 28,39% | 36,49% | 9,23% | 151,63% |
| LYXOR MSCI WORLD UCITS ETF MONTHLY HEDGED TO EUR DIST | RVI GLOBAL | 16,13% | 58,05% | 59,87% | 151,63% |
| GOLDMAN SACHS GLOBAL EQUITY PARTNERS ESG PORTFOLIO R USD CAP | RVI GLOBAL | -2,98% | 27,75% | 39,52% | 151,62% |
| VALENTUM, FI E | RVI GLOBAL VALOR | 39,16% | 44,50% | 35,22% | 151,62% |
| AXA WORLD FUNDS-SWITZERLAND EQUITY F DIS CHF | RVI EUROPA | 9,19% | 23,74% | 33,79% | 151,59% |
| BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES B USD | SALUD | -9,53% | 8,85% | 16,59% | 151,59% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 25,16% | 41,39% | 49,32% | 151,58% |
| SCHRODER ISF ASIAN OPPORTUNITIES A ACC EUR | RVI ASIA EX-JAPÓN | 27,39% | 31,47% | 15,86% | 151,57% |
| SCHRODER ISF ASIAN OPPORTUNITIES A ACC NOK | RVI ASIA EX-JAPÓN | 27,54% | 31,15% | 15,72% | 151,55% |
